{"id":"W3031004830","doi":"10.1200/jco.2020.38.15_suppl.10022","title":"A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Logistic regression","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001766482,0.002226477,0.001860473,0.0004720283,0.0004714021,0.001348119,0.0009250177,0.001119997,0.005677565],"category_scores_gemma":[0.0008586105,0.0006803724,0.001127622,0.0004787538,0.000791828,0.001114586,0.0004578138,0.002964042,0.001542119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001400859,"about_ca_system_score_gemma":0.00172881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001496001,"about_ca_topic_score_gemma":0.003450548,"domain_scores_codex":[0.9995371,0.0002211896,0.00001505331,0.00009492947,0.00003586865,0.00009591033],"domain_scores_gemma":[0.9992771,0.00007518418,0.0001075188,0.00006363856,0.00004223951,0.0004342599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8338248,0.08499163,0.006115321,0.0003876019,0.0009701949,0.0002171987,0.0002726278,0.002134127,0.01833554,0.0002279342,0.003573633,0.0489494],"study_design_scores_gemma":[0.5757476,0.4104956,0.008405678,0.00001977468,0.0003207004,0.0002152426,0.0000774092,0.001096881,0.001498855,0.0001616967,0.001927943,0.00003255621],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927368,0.0008729553,0.0004008371,0.0003217258,0.0001112894,0.002489833,0.001186536,0.00008300702,0.001797107],"genre_scores_gemma":[0.9865065,0.0009618979,0.001650615,0.0007571121,0.0001619521,0.00271742,0.003163064,0.00004832865,0.004033197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005677565,"threshold_uncertainty_score":0.01899332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03068166014931388,"score_gpt":0.3795145801353735,"score_spread":0.3488329199860596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}